McGrath Lynne Fahey

Director at ALZN

Sold, on record
$69
Dollars the filings state
Form 4 sales
1
Latest Oct 23, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ALZNAlzamend Neuro, Inc.Director

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale ALZNUnusual
    Oct 23, 2025 2025

    Sold 30 shares at $2.29 ($69)

    McGrath Lynne Fahey, Director

    No 10b5-1 planSold 54.5% of holdings ($126 position)25 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by McGrath Lynne Fahey
Source
Oct 23, 2025Oct 24, 2025ALZNDirectorForm 4 sale30$6954.5%UnusualSEC